CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Levothyroxine Sodium

左甲状腺素钠 杂质对照品Levothyroxine Sodium Impurities

EP56 个杂质条目56 impurity entries

本页汇总 左甲状腺素钠 的 56 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 56 impurity reference standards of Levothyroxine Sodium with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 左甲状腺素钠(Levothyroxine Sodium)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment of levothyroxine sodium pediatric oral solution driven by STEP database: Stability study and degradation products by LC-MS
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2026 · Camboim BL et al.  ·  PMID 42097333  ·  DOI
  2. 杂质研究Impurity studiesLevothyroxine sodium revisited: A wholistic structural elucidation approach of new impurities via HPLC-HRMS/MS, on-line H/D exchange, NMR spectroscopy and chemical synthesis
    Journal of pharmaceutical and biomedical analysis · 2017 · Ruggenthaler M et al.  ·  PMID 28024262  ·  DOI
  3. 杂质研究Impurity studiesDevelopment and Validation of an Assay Method for Levothyroxine Soft Gelatin Capsules Utilizing the RP-HPLC Technique
    Biomedical chromatography : BMC · 2026 · Katari N et al.  ·  PMID 41467709  ·  DOI
  4. 分析方法Analytical MethodsDevelopment and validation of a high-performance liquid chromatography method for levothyroxine sodium quantification in plasma for pre-clinical evaluation of long-acting drug delivery systems
    Analytical methods : advancing methods and applications · 2021 · Permana AD et al.  ·  PMID 34676387  ·  DOI
  5. 分析方法Analytical MethodsA Comparative pH-Dissolution Profile Analysis of Selected Commercial Levothyroxine Formulations in Lebanon Using Anion-Exchange HPLC Method: Implication on Interchangeability
    Advances in pharmacological and pharmaceutical sciences · 2025 · AlBathish M et al.  ·  PMID 41030590  ·  DOI

左甲状腺素钠 —— 原料药与杂质对照品Levothyroxine Sodium — drug substance & impurities

共 56 个条目(含原料药本体)56 items incl. the drug substance
Levothyroxine Sodium structure
EP原料药 APIAPI
左甲状腺素钠Levothyroxine Sodium
Levothyroxine Sodium
CAS No.55-03-8
Chemical FormulaC15H10I4NO4-·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 1(Levothyroxine Sodium EP Impurity A) structure
EPA
左甲状腺素钠杂质1(左甲状腺素钠EP杂质A)Levothyroxine Sodium Impurity 1(Levothyroxine Sodium EP Impurity A)
Levothyroxine Sodium Impurity 1(Levothyroxine Sodium EP Impurity A)
CAS No.6893-02-3
Chemical FormulaC15H12I3NO4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 2(Levothyroxine Sodium EP Impurity B) structure
EPB
左甲状腺素钠杂质2(左甲状腺素钠EP杂质B)Levothyroxine Sodium Impurity 2(Levothyroxine Sodium EP Impurity B)
Levothyroxine Sodium Impurity 2(Levothyroxine Sodium EP Impurity B)
CAS No.1628720-66-0
Chemical FormulaC15H11ClI3NO4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 3(Levothyroxine Sodium EP Impurity C) structure
EPC
左甲状腺素钠杂质3(左甲状腺素钠EP杂质C)Levothyroxine Sodium Impurity 3(Levothyroxine Sodium EP Impurity C)
Levothyroxine Sodium Impurity 3(Levothyroxine Sodium EP Impurity C)
CAS No.51-24-1
Chemical FormulaC14H9I3O4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 4(Levothyroxine Sodium EP Impurity D) structure
EPD
左甲状腺素钠杂质4(左甲状腺素钠EP杂质D)Levothyroxine Sodium Impurity 4(Levothyroxine Sodium EP Impurity D)
Levothyroxine Sodium Impurity 4(Levothyroxine Sodium EP Impurity D)
CAS No.67-30-1
Chemical FormulaC14H8I4O4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 5(Levothyroxine Sodium EP Impurity E) structure
EPE
左甲状腺素钠杂质5(左甲状腺素钠EP杂质E)Levothyroxine Sodium Impurity 5(Levothyroxine Sodium EP Impurity E)
Levothyroxine Sodium Impurity 5(Levothyroxine Sodium EP Impurity E)
CAS No.1041-01-6
Chemical FormulaC15H13I2NO4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 6(Levothyroxine Sodium EP Impurity F) structure
EPF
左甲状腺素钠杂质6(左甲状腺素钠EP杂质F)Levothyroxine Sodium Impurity 6(Levothyroxine Sodium EP Impurity F)
Levothyroxine Sodium Impurity 6(Levothyroxine Sodium EP Impurity F)
CAS No.911661-90-0
Chemical FormulaC21H13I6NO5
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 7(Levothyroxine Sodium EP Impurity H) structure
EPH
左甲状腺素钠杂质7(左甲状腺素钠EP杂质H)Levothyroxine Sodium Impurity 7(Levothyroxine Sodium EP Impurity H)
Levothyroxine Sodium Impurity 7(Levothyroxine Sodium EP Impurity H)
CAS No.2055-97-2
Chemical FormulaC13H6I4O4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 8 (Levothyroxine Sodium EP Impurity I) structure
EPI
左甲状腺素钠杂质8 (左甲状腺素钠EP杂质I)Levothyroxine Sodium Impurity 8 (Levothyroxine Sodium EP Impurity I)
Levothyroxine Sodium Impurity 8 (Levothyroxine Sodium EP Impurity I)
CAS No.2016-06-0
Chemical FormulaC13H6I4O3
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 9 (Levothyroxine Sodium EP Impurity J) structure
EPJ
左甲状腺素钠杂质9 (左甲状腺素钠EP杂质J)Levothyroxine Sodium Impurity 9 (Levothyroxine Sodium EP Impurity J)
Levothyroxine Sodium Impurity 9 (Levothyroxine Sodium EP Impurity J)
CAS No.4604-41-5
Chemical FormulaC15H13I2NO4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 10 (Levothyroxine Sodium EP Impurity K) structure
EPK
左甲状腺素钠杂质10 (左甲状腺素钠EP杂质K)Levothyroxine Sodium Impurity 10 (Levothyroxine Sodium EP Impurity K)
Levothyroxine Sodium Impurity 10 (Levothyroxine Sodium EP Impurity K)
CAS No.5817-39-0
Chemical FormulaC15H12I3NO4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 8-13C6 (Levothyroxine Sodium EP Impurity I-13C6) structure
EPI-13C6
左甲状腺素钠杂质8-13C6 (左甲状腺素钠EP杂质I-13C6)Levothyroxine Sodium Impurity 8-13C6 (Levothyroxine Sodium EP Impurity I-13C6)
Levothyroxine Sodium Impurity 8-13C6 (Levothyroxine Sodium EP Impurity I-13C6)
CAS No.1346601-51-1
Chemical FormulaC713C6H6I4O3
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 11 structure
11
左甲状腺素钠杂质11Levothyroxine Sodium Impurity 11
Levothyroxine Sodium Impurity 11
CAS No.2230724-39-5
Chemical FormulaC15H13I4NO2
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 12 structure
12
左甲状腺素钠杂质12Levothyroxine Sodium Impurity 12
Levothyroxine Sodium Impurity 12
CAS No.671235-41-9
Chemical FormulaC16H11I4NO5
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 13 structure
13
左甲状腺素钠杂质13Levothyroxine Sodium Impurity 13
Levothyroxine Sodium Impurity 13
CAS No.909279-46-5
Chemical FormulaC15H11ClI3NO4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 14 structure
14
左甲状腺素钠杂质14Levothyroxine Sodium Impurity 14
Levothyroxine Sodium Impurity 14
CAS No.176258-88-1
Chemical FormulaC14H9I4NO3
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 15 structure
15
左甲状腺素钠杂质15Levothyroxine Sodium Impurity 15
Levothyroxine Sodium Impurity 15
CAS No.76353-71-4
Chemical FormulaC17H15I4NO4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 16 structure
16
左甲状腺素钠杂质16Levothyroxine Sodium Impurity 16
Levothyroxine Sodium Impurity 16
CAS No.93647-48-4
Chemical FormulaC14H8I4O5
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 17 structure
17
左甲状腺素钠杂质17Levothyroxine Sodium Impurity 17
Levothyroxine Sodium Impurity 17
CAS No.107849-54-7
Chemical FormulaC15H11I4NO5
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 18 structure
18
左甲状腺素钠杂质18Levothyroxine Sodium Impurity 18
Levothyroxine Sodium Impurity 18
CAS No.26041-51-0
Chemical FormulaC17H13I4NO5
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 19 structure
19
左甲状腺素钠杂质19Levothyroxine Sodium Impurity 19
Levothyroxine Sodium Impurity 19
CAS No.5563-89-3
Chemical FormulaC15H13I2NO4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 20 structure
20
左甲状腺素钠杂质20Levothyroxine Sodium Impurity 20
Levothyroxine Sodium Impurity 20
CAS No.3078-39-5
Chemical FormulaC9H10INO3
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 21 structure
21
左甲状腺素钠杂质21Levothyroxine Sodium Impurity 21
Levothyroxine Sodium Impurity 21
CAS No.66-02-4
Chemical FormulaC9H9I2NO3
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 22 structure
22
左甲状腺素钠杂质22Levothyroxine Sodium Impurity 22
Levothyroxine Sodium Impurity 22
CAS No.51-26-3
Chemical FormulaC15H11I3O4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 25 structure
25
左甲状腺素钠杂质25Levothyroxine Sodium Impurity 25
Levothyroxine Sodium Impurity 25
CAS No.7069-47-8
Chemical FormulaC15H10I4O5
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 27 structure
27
左甲状腺素钠杂质27Levothyroxine Sodium Impurity 27
Levothyroxine Sodium Impurity 27
CAS No.30804-52-5
Chemical FormulaC19H17I4NO5
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 28 structure
28
左甲状腺素钠杂质28Levothyroxine Sodium Impurity 28
Levothyroxine Sodium Impurity 28
CAS No.4192-14-7
Chemical FormulaC15H13I2NO4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 29 structure
29
左甲状腺素钠杂质29Levothyroxine Sodium Impurity 29
Levothyroxine Sodium Impurity 29
CAS No.4732-82-5
Chemical FormulaC15H14INO4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 30 structure
30
左甲状腺素钠杂质30Levothyroxine Sodium Impurity 30
Levothyroxine Sodium Impurity 30
CAS No.2088032-78-2
Chemical FormulaC14H9I4NO3
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 31 structure
31
左甲状腺素钠杂质31Levothyroxine Sodium Impurity 31
Levothyroxine Sodium Impurity 31
CAS No.1155-40-4
Chemical FormulaC14H10I2O4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 34 structure
34
左甲状腺素钠杂质34Levothyroxine Sodium Impurity 34
Levothyroxine Sodium Impurity 34
CAS No.2278-95-7
Chemical FormulaC15H8I4O4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 35 structure
35
左甲状腺素钠杂质35Levothyroxine Sodium Impurity 35
Levothyroxine Sodium Impurity 35
CAS No.3571-49-1
Chemical FormulaC14H11I4NO2
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 36 structure
36
左甲状腺素钠杂质36Levothyroxine Sodium Impurity 36
Levothyroxine Sodium Impurity 36
CAS No.3914-31-6
Chemical FormulaC15H11I3O4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 37 structure
37
左甲状腺素钠杂质37Levothyroxine Sodium Impurity 37
Levothyroxine Sodium Impurity 37
CAS No.92151-30-9
Chemical FormulaC14H9I3O4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 38 structure
38
左甲状腺素钠杂质38Levothyroxine Sodium Impurity 38
Levothyroxine Sodium Impurity 38
CAS No.2984253-88-3
Chemical FormulaC16H14I4N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 39 structure
39
左甲状腺素钠杂质39Levothyroxine Sodium Impurity 39
Levothyroxine Sodium Impurity 39
CAS No.21462-56-6
Chemical FormulaC21H19I4NO10
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 42 structure
42
左甲状腺素钠杂质42Levothyroxine Sodium Impurity 42
Levothyroxine Sodium Impurity 42
CAS No.2186640-82-2
Chemical FormulaC16H9BrFNO2
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 43 structure
43
左甲状腺素钠杂质43Levothyroxine Sodium Impurity 43
Levothyroxine Sodium Impurity 43
CAS No.1672665-55-2
Chemical FormulaC17H12FNO4S
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 44 structure
44
左甲状腺素钠杂质44Levothyroxine Sodium Impurity 44
Levothyroxine Sodium Impurity 44
CAS No.1672668-41-5
Chemical FormulaC19H14FNO6S
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 45 structure
45
左甲状腺素钠杂质45Levothyroxine Sodium Impurity 45
Levothyroxine Sodium Impurity 45
CAS No.70-78-0
Chemical FormulaC9H10INO3
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 47 structure
47
左甲状腺素钠杂质47Levothyroxine Sodium Impurity 47
Levothyroxine Sodium Impurity 47
CAS No.70-39-3
Chemical FormulaC15H12I3NO4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 49 structure
49
左甲状腺素钠杂质49Levothyroxine Sodium Impurity 49
Levothyroxine Sodium Impurity 49
CAS No.153324-21-1
Chemical FormulaC13H13I2NO5
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 50 structure
50
左甲状腺素钠杂质50Levothyroxine Sodium Impurity 50
Levothyroxine Sodium Impurity 50
CAS No.886203-79-8
Chemical FormulaC18H17I2NO5
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 51 structure
51
左甲状腺素钠杂质51Levothyroxine Sodium Impurity 51
Levothyroxine Sodium Impurity 51
CAS No.56460-41-4
Chemical FormulaC12H13I2NO4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 52 structure
52
左甲状腺素钠杂质52Levothyroxine Sodium Impurity 52
Levothyroxine Sodium Impurity 52
CAS No.28841-76-1
Chemical FormulaC13H16INO4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 56 structure
56
左甲状腺素钠杂质56Levothyroxine Sodium Impurity 56
Levothyroxine Sodium Impurity 56
CAS No.2055-94-9
Chemical FormulaC13H8I4O3
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 59 structure
59
左甲状腺素钠杂质59Levothyroxine Sodium Impurity 59
Levothyroxine Sodium Impurity 59
CAS No.176258-87-0
Chemical FormulaC14H11I3O2
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 60 structure
60
左甲状腺素钠杂质60Levothyroxine Sodium Impurity 60
Levothyroxine Sodium Impurity 60
CAS No.92905-78-7
Chemical FormulaC14H10I3NO3
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 61 structure
61
左甲状腺素钠杂质61Levothyroxine Sodium Impurity 61
Levothyroxine Sodium Impurity 61
CAS No.16170-92-6
Chemical FormulaC15H14INO4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 62 structure
62
左甲状腺素钠杂质62Levothyroxine Sodium Impurity 62
Levothyroxine Sodium Impurity 62
CAS No.712349-95-6
Chemical FormulaC14H14INO2
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 62 Hydrochloride structure
62
左甲状腺素钠杂质62 盐酸盐Levothyroxine Sodium Impurity 62 Hydrochloride
Levothyroxine Sodium Impurity 62 Hydrochloride
CAS No.788824-64-6
Chemical FormulaC14H14INO2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 63 structure
63
左甲状腺素钠杂质63Levothyroxine Sodium Impurity 63
Levothyroxine Sodium Impurity 63
CAS No.10468-90-3
Chemical FormulaC15H14INO4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 64 structure
64
左甲状腺素钠杂质64Levothyroxine Sodium Impurity 64
Levothyroxine Sodium Impurity 64
CAS No.16711-71-0
Chemical FormulaC9H9I2NO3
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 65 structure
65
左甲状腺素钠杂质65Levothyroxine Sodium Impurity 65
Levothyroxine Sodium Impurity 65
CAS No.1027-28-7
Chemical FormulaC11H11I2NO4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 66 structure
66
左甲状腺素钠杂质66Levothyroxine Sodium Impurity 66
Levothyroxine Sodium Impurity 66
CAS No.21959-36-4
Chemical FormulaC13H15I2NO4
Purity>95%询价On request
10mg25mg50mg100mg
Levothyroxine Sodium Impurity 67 structure
67
左甲状腺素钠杂质67Levothyroxine Sodium Impurity 67
Levothyroxine Sodium Impurity 67
CAS No.1798033-11-0
Chemical FormulaC21H13I6NO5
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

左甲状腺素钠 —— 研究文献与合成路线Levothyroxine Sodium — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 左甲状腺素钠 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Levothyroxine Sodium. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Levothyroxine sodium revisited: A wholistic structural elucidation approach of new impurities via HPLC-HRMS/MS, on-line H/D exchange, NMR spectroscopy and chemical synthesis
    Ruggenthaler M, Grass J, Schuh W, et al. · Journal of pharmaceutical and biomedical analysis · 2017 · 被引 6cited 6
  2. AN IMPROVED PROCESS FOR THE PREPARATION OF LEVOTHYROXINE SODIUM WITH REDUCED LEVELS OF IMPURITIES
    KHAMAR BAKULESH MAFATLAL, GURUSAMY RENUGADEVI, RAVI MARUTI NAIK, et al. · 2009
  3. Reversed-phase high-performance liquid chromatographic analysis of liothyronine sodium and levothyroxine sodium in tablet formulations: preliminary studies on dissolution and content uniformity
    Rapaka RS, Knight PW, Prasad VK · Journal of pharmaceutical sciences · 1981 · 被引 11cited 11

合成与制备工艺专利Synthesis & process patents

  1. AN IMPROVED PROCESS FOR THE PREPARATION OF LEVOTHYROXINE SODIUM WITH REDUCED LEVELS OF IMPURITIES
    KHAMAR BAKULESH MAFATLAL, GURUSAMY RENUGADEVI, RAVI MARUTI NAIK, REDDY VEDURURI MADHAVA, et al. · 公开号 WO2009136249WO2009136249 · 2009
  2. PHARMACEUTICAL PREPARATION CONTAINING LEVOTHYROXINE SODIUM
    NISCHWITZ Marion, SCHREDER Sven · 公开号 EP1077681EP1077681 · 2001
  3. PHARMACEUTICAL PREPARATION CONTAINING LEVOTHYROXINE SODIUM
    SCHREDER Sven, NISCHWITZ Marion · 公开号 WO9959551WO9959551 · 1999

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

左甲状腺素钠 杂质谱研究要点Levothyroxine Sodium — impurity profiling notes

下面这些是拿到 左甲状腺素钠 的 56 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 56 impurity entries for Levothyroxine Sodium, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances